An observational study in Coronary Artery Bypass, Anesthesia and Sustainability, sponsored by Universidad de La Frontera. Recruiting at 1 site in Chile. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-02.
Sponsored by Universidad de La Frontera · Observational
I• Introduction:
Today, it is clear that protecting human health without ensuring a healthy environment is counterproductive. The 2020 Helsinki Declaration calls for "awareness of the strong interrelationship between human and planetary health". Due to greenhouse gases (GHG), we face the so-called "climate emergency," as climate change threatens the health and security of humanity. However, the healthcare industry is one of the main sources of pollutants and GHG. In the US, the healthcare sector alone is responsible for 9-10% of national GHG emissions and other toxic emissions, amounting to 123,000-381,000 DALYs per year (Disability-Adjusted Life Years). Hospitals account for significant resource consumption and waste and are responsible for almost half of the healthcare sector's GHG emissions. In the healthcare sector, operating rooms account for at least 30% of a hospital's total waste. In a hospital, emissions from anesthetic procedures stand out due to the use of certain drugs and clinical gases, which alone can account for more than 45% of a high-complexity center's CO2e emissions. Therefore, environmental sustainability is becoming a crucial aspect for anesthesiology.
To assess the environmental impact of a clinical practice, a life-cycle assessment (LCA) is necessary. This is an environmental evaluation of products, systems, or services that quantifies the environmental impacts generated throughout their life cycle. CO2e emissions are the most important impact indicator or category due to their role in climate change, harm to human health (expressed in DALY), damage to ecosystems, and resource depletion. Life cycle assessment studies of clinical services include: childbirth procedures, hysterectomy, hemodialysis and peritoneal dialysis, plastic surgery, cataract extraction, laparoscopic procedures, and intensive care.
Within medical and surgical services, myocardial revascularization surgery is one of the procedures that uses the most operating room resources, a space where the highest GHG emissions have been reported, with the greatest resource and energy consumption.
On the other hand, clinical effectiveness in relation to the perioperative period, of myocardial revascularization surgery, has a new paradigm especially for anesthesiology: "enhanced recovery" or "optimized recovery" has has been associated with a decrease in postoperative respiratory complications and a greater likelihood of early extubation, shortening stays in intensive care units and hospitals, which could be reflected in lower costs associated with this type of care.
Sustainability is defined by three pillars: economic, social, and environmental dimensions. Thus, a sustainable anesthetic strategy for coronary heart surgery, compared to other anesthetic techniques, would aim for a reduction in current costs (economic), mitigate its impact by identifying critical points of CO2 emissions (environmental impact), and achieve better clinical effectiveness with an optimized recovery anesthetic strategy in terms of extubation time (social dimension). This is the problem we wish to address: how to make anesthetic practice sustainable by studying an optimized recovery technique in one of the most complex and resource-intensive surgical procedures, myocardial revascularization.
General objective:
To establish the relative sustainability of the optimized recovery anesthetic technique with respect to the usual anesthetic practice in myocardial revascularization surgery performed at the Hernán Henríquez Aravena Hospital in Temuco.
Specific objectives:
This project will conduct a non-randomized interventional study and implement an optimized anesthetic recovery strategy for coronary artery bypass graft surgery. This study will perform a sustainability analysis of an optimized recovery anesthetic technique compared to a usual anesthetic practice for myocardial revascularization surgery at the Hernán Henríquez Aravena Hospital in Temuco (HHHA).
The anesthetic strategies to be compared are common practice or standard anesthetic practice (SAP) and the proposed optimized recovery (OR) approach.
The sample size calculation is based on the primary variable, the number of hours of mechanical ventilation (extubation time), comparing SAP with the OR approach. The expected mean and standard deviation for SAP were obtained from the cardiovascular ICU's continuous record database for a six-month period in 2023: 4.6 hours and 3.3 hours, respectively. OR is expected to reduce the mean time by 2 hours while maintaining the same recorded variability. For the sample size calculation, a 95% confidence level, 80% statistical power, and a 1:3 ratio, a sample size of 29 patients was estimated for the OR group and 87 for the SAP group, for a total of 116 patients.
Feasibility and Sampling: The hospital performs 500 cardiac surgeries annually, 350 of which are coronary artery bypass grafts. Patients will be selected consecutively. Allocation method: Four anesthesiologists will be included in the study. Only one anesthesiologist will perform the OR technique, and the results will be compared with those of the other three, who will apply their SAP. The selection of the single anesthesiologist who will perform the procedure will be based on convenience. Masking: Anesthesiologists not exposed to the procedure will continue to administer anesthesia using their usual technique, on days other than the day the OR technique is performed, independently of the patients' surgical schedule. The anesthesiologist will be masked for data analysis.
Clinical variables: Patient variables: age, weight, and height. Medical history or concomitant pathology. Anesthesia variables: drugs used, anesthesia duration, resources, and energy used. Surgical variables: number of coronary artery bypass grafts, surgical time, and length of stay in the operating room. ICU variables: extubation time and length of stay in the ICU.
Data Collection: Data and information on supplies will be obtained from the hospital database and directly collected during each procedure, after obtaining informed consent. Only the outcome variable, ICU extubation time, will be recorded outside the system boundaries.
Economic Analysis: The cost of the intervention will be updated and described, including marginal, incremental, and average costs. Direct costs will be estimated using micro-costing techniques. Direct healthcare costs associated with the health technologies used, such as medications, medical devices, and care provided by healthcare professionals, among others, will be measured and quantified. The labor cost of each professional participating in the interventions will be quantified by measuring the number of minutes each professional works. The costs of infrastructure use (electricity, water, heating, operating room time, operating room fees) used in each procedure will be determined as follows: Depreciation of equipment and infrastructure will not be included. The cost will have an operational focus.
Environmental Impact Analysis: The life-cycle assessment will be conducted in accordance with the methods established in ISO 14040 (2006a) and ISO 14044 (2006b). These will consider: The scope, which will encompass inputs from "cradle to grave", including those used to perform each anesthetic procedure from the moment the patient enters the operating room until they leave. The functional unit is an adult patient under anesthesia for 1 hour, weighing an average of 70 kg, and the reference flow will be the quantity of anesthetics and other supplies used during a myocardial revascularization surgery. The system boundaries encompass the extraction of raw materials, production, use, and end-of-life of the processes and products required for each type of anesthetic technique, from the moment the patient enters the operating room until they leave. Next, a life cycle inventory analysis will be conducted. Information and costs for each procedure will be obtained from the hospital's electronic records. Real-time data will be obtained on the quantities of medications used and waste generated, and the details of each component will be quantified. The impacts from waste transportation will be calculated based on distances from the hospital to the landfill and recycling facilities. Electricity consumption will be quantified directly in each operating room. An environmental impact study will be conducted using the CCALC database and OpenLCA software to estimate CO2e emissions. Finally, significant environmental flows and aspects (emissions, resources, waste, inputs, etc.) will be identified, along with the life-cycle stage at which they occur and the critical points. The resulting harm to human health, measured in DALYs, will also be estimated.
Sustainability Analysis: After establishing the clinical effectiveness of the intervention in terms of extubation times, the sustainability of each intervention will be evaluated by analyzing updated anesthesia costs for myocardial revascularization surgery and the critical environmental impacts per hour of anesthetized patient in the operating room (functional unit). This will yield an indicator expressed as costs in Euros/critical points of environmental damage (CO2e) per hour of an anesthetized patient in the operating room, using this as the average value of the ratio.
Patients with coronary artery disease scheduled for coronary artery bypass graft surgery at Dr. Hernán Henríquez Aravena Hospital in Temuco.
Exclusion Criteria:
A sustainable anesthetic technique for myocardial revascularization surgery to reduce costs, mitigate its environmental impact, and achieve the best clinical effectiveness in terms of extubation time.
Procedure: Optimized recovery
The common practice or routine anesthetic practice
Other: Standard Anesthetic Practice
Preoperative: Initiate oral pregabalin 75 mg the night before surgery. Fast from light food for 6 hours preoperatively. 2 hours of clear liquids. Do not administer benzodiazepines preoperatively. Intraoperative: Induction and maintenance of anesthesia with propofol. Opioids: intravenous (IV) fentanyl as required, methadone 0.2 mg/kg IV once. Post-induction: Erector spinae plane block with 0.25% bupivacaine solution, 20 ml per side, once. Prophylaxis of postoperative nausea and vomiting with dexamethasone 8 mg IV once in non-diabetic patients or 4 mg IV once in diabetic patients. Intraoperative intravenous analgesia: Metamizole IV every 6 hours. Low flow rates of clinical gases (oxygen and air).
The common practice or the standard practice anesthetic technique involves the anesthesiologist administering anesthesia routinely, without changes.
Sustainability result
To make an appropriate comparison, the average values of the ratio for each anesthetic strategy or intervention will be considered, interms of: • Costs (Euros)/Carbon Footprint (CO2e)/Time elapsed until extubation (min).
Time frame: From the moment he enters the operating room until the endotracheal tube is removed in the ICU.
Clinical effectiveness
Time elapsed from the patient's admission to the ICU until extubation for each intervention.
Time frame: Time elapsed from the patient's admission to the ICU until their extubation for each intervention, in minutes.
Environmental Impact Analysis
Life Cycle Assessment results: The indicator is climate change, through impact categories such as CO2e, the analysis of which will determine the critical environmental impact points (CPs) resulting from the analytical work.
Time frame: Time elapsed from the patient's entry into the operating room until their exit.
Cost analysis
For each intervention, the average cost per patient or per intervention and the incremental cost will be measured.
Time frame: Time elapsed from the patient's entry into the operating room until their exit.
Harm/benefit to human health.
Damages/benefits to human health: the DALYs generated by both anesthetic techniques and the DALYs avoided by the intervention will be estimated.
Time frame: From the moment he enters the operating room until the endotracheal tube is removed in the ICU.
Plan to share: Yes — The full database will be accessible in the publication through a provided link.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universidad de La Frontera